These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29277535)

  • 1. Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods.
    Metsu D; Lanot T; Fraissinet F; Picot M; Concordet D; Cabrol M; Dubois-Galopin F; Chatelut E; Delobel P; Gandia P
    Clin Chim Acta; 2018 Apr; 479():56-65. PubMed ID: 29277535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of unbound fraction of dorzagliatin in human plasma by equilibrium dialysis and LC-MS/MS and its application to a clinical pharmacokinetic study.
    Yang R; Ren S; Jin X; Sun Y; Dong Y; Zhang J; Liang W; Chen L
    J Pharm Biomed Anal; 2021 Feb; 195():113854. PubMed ID: 33388639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a simple and rapid method to determine the unbound fraction of dolutegravir, raltegravir and darunavir in human plasma using ultrafiltration and LC-MS/MS.
    Zheng Y; Lui G; Boujaafar S; Aboura R; Bouazza N; Foissac F; Treluyer JM; Benaboud S; Hirt D; Gana I
    J Pharm Biomed Anal; 2021 Mar; 196():113923. PubMed ID: 33571728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring?
    Metsu D; Seraissol P; Delobel P; Cinq-Frais C; Cuzin L; Izopet J; Chatelut E; Gandia P
    Fundam Clin Pharmacol; 2017 Apr; 31(2):245-253. PubMed ID: 27664801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of unbound ticagrelor and its active metabolite (AR-C124910XX) in human plasma by equilibrium dialysis and LC-MS/MS.
    Sillén H; Cook M; Davis P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2315-22. PubMed ID: 21727045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.
    Imbs DC; Paludetto MN; Négrier S; Powell H; Lafont T; White-Koning M; Chatelut E; Thomas F
    Invest New Drugs; 2016 Feb; 34(1):41-8. PubMed ID: 26572909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring unbound versus total vancomycin concentrations in serum and plasma: methodological issues and relevance.
    Stove V; Coene L; Carlier M; De Waele JJ; Fiers T; Verstraete AG
    Ther Drug Monit; 2015 Apr; 37(2):180-7. PubMed ID: 25072945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of equilibrium dialysis UHPLC-MS/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma. Application to patients with HIV.
    Rigo-Bonnin R; García-Tejada L; Mas-Bosch V; Imaz A; Manuel Tiraboschi J; Scévola S; Niubó J; Navarro-Alcaraz A; Podzamczer D
    Clin Chim Acta; 2024 Jan; 552():117678. PubMed ID: 38042460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of total and unbound concentrations of lopinavir in plasma using liquid chromatography-tandem mass spectrometry and ultrafiltration methods.
    Illamola SM; Labat L; Benaboud S; Tubiana R; Warszawski J; Tréluyer JM; Hirt D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():216-23. PubMed ID: 25049210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing ultrafiltration and equilibrium dialysis to measure unbound plasma dolutegravir concentrations based on a design of experiment approach.
    Metsu D; Lanot T; Fraissinet F; Concordet D; Gayrard V; Averseng M; Ressault A; Martin-Blondel G; Levade T; Février F; Chatelut E; Delobel P; Gandia P
    Sci Rep; 2020 Jul; 10(1):12265. PubMed ID: 32703975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of unbound vismodegib (GDC-0449) concentration in human plasma using rapid equilibrium dialysis followed by solid phase extraction and high-performance liquid chromatography coupled to mass spectrometry.
    Deng Y; Wong H; Graham RA; Liu W; Shen HS; Shi Y; Wang L; Meng M; Malhi V; Ding X; Dean B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2119-26. PubMed ID: 21704573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a robust ultrafiltration-LC-MS/MS method for quantitative analysis of unbound vadimezan (ASA404) in human plasma.
    Li W; Lin H; Smith HT; Tse FL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1927-33. PubMed ID: 21680264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Confidence in the Determination of Free Fraction for Highly Bound Drugs Using Bidirectional Equilibrium Dialysis.
    Chen YC; Kenny JR; Wright M; Hop CECA; Yan Z
    J Pharm Sci; 2019 Mar; 108(3):1296-1302. PubMed ID: 30326208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bionalytical validation study for the determination of unbound ambrisentan in human plasma using rapid equilibrium dialysis followed by ultra performance liquid chromatography coupled to mass spectrometry.
    Garcia-Martínez S; Rico E; Casal E; Grisaleña A; Alcaraz E; King N; Leal N; Navarro I; Campanero MÁ
    J Pharm Biomed Anal; 2018 Feb; 150():427-435. PubMed ID: 29289894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Simple and Rapid Method to Measure the Free Fraction of Tacrolimus in Plasma Using Ultrafiltration and LC-MS/MS.
    Stienstra NA; Sikma MA; van Dapperen AL; de Lange DW; van Maarseveen EM
    Ther Drug Monit; 2016 Dec; 38(6):722-727. PubMed ID: 27805928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A validated LC-MS/MS method of total and unbound lenvatinib quantification in human serum for protein binding studies by equilibrium dialysis.
    Mano Y; Kusano K
    J Pharm Biomed Anal; 2015 Oct; 114():82-7. PubMed ID: 26026266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Counter Equilibrium Dialysis (CED) to Increase Confidence in the Measurement of Free Fraction for Challenging Compounds.
    Huang J; Yan Z; Cai J
    J Pharm Sci; 2023 Sep; 112(9):2561-2569. PubMed ID: 37187260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?
    Gandia P; Arellano C; Lafont T; Huguet F; Malard L; Chatelut E
    Cancer Chemother Pharmacol; 2013 Feb; 71(2):531-6. PubMed ID: 23183914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A liquid chromatography-tandem mass spectrometry assay for quantification of rilpivirine and dolutegravir in human plasma.
    Grégoire M; Deslandes G; Renaud C; Bouquié R; Allavena C; Raffi F; Jolliet P; Dailly E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():1-9. PubMed ID: 25261833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro plasma protein binding determination of flunarizine using equilibrium dialysis and liquid chromatography-tandem mass spectrometry.
    Lin ZJ; Musiano D; Abbot A; Shum L
    J Pharm Biomed Anal; 2005 Apr; 37(4):757-62. PubMed ID: 15797798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.